Used in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) that target neurological disorders. It serves as a key intermediate in the production of molecules with potential antidepressant or antipsychotic properties. Its trifluoromethyl group enhances the metabolic stability and bioavailability of the final drug products. Additionally, it is employed in organic chemistry research to explore novel reactions and pathways involving fluorinated compounds. Its hydrochloride form ensures better solubility and handling in various chemical processes.